Inclusion Criteria:  NASH will be diagnosed by liver biopsy or ultrasound steatosis / Fibroscan CAP > 250 dB + any 1 criteria of metabolic syndrome:  Waist circumference 90 ≥ cm for males or ≥80 cm for females Triglycerides ≥150 mg/dL HDL-C < 40 mg/dL in males or < 50 mg/dl in females systolic blood pressure (SBP) ≥130 mm Hg or diastolic blood pressure (DBP) ≥ 85 mmHg or both and Fasting plasma glucose ≥ 100 mg/dL. cACLD is defined with Liver stiffness ≥10 kPa. Ultrasound examination, blood examination and upper gastrointestinal endoscopy will be performed within 1 month of Fibroscan examination. HVPG if indicated will be done within 1 month of Fibroscan. Patients of viral hepatitis (HBV / HCV) related cACLD will be taken as control.  Exclusion Criteria:  Age < 18 and > 70 years, BMI > 35, past or present history of decompensation (ascites, variceal bleed, hepatic encephalopathy, jaundice), Child Pugh B or C, unreliable liver and splenic stiffness in Fibroscan examination, Transjugular intrahepatic portosystemic shunt, significant alcohol intake (> 20gm/day in last year), Acute on chronic liver failure, AST/ALT > 100 IU/l, Hepatocellular carcinoma or any space-occupying lesion in the liver, Portal vein thrombosis, Biliary obstruction, HVOTO, Cardiac failure, Prior variceal endotherapy or ongoing beta blocker treatment for varices, HIV, Any malignancy, Pregnancy, ICD / pacemaker, No consent.